Search results
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 6 days agoSource: GuruFocus Conclusion In our assessment, increased competition in the global cancer therapeutics market from Merck (NYSE:MRK) and AstraZeneca...
Glecirasib Shows Promising Efficacy in KRAS-Mutated NSCLC
MedPage Today· 7 days agoTrend towards better response rate, PFS compared with approved KRAS inhibitors
Vanguard Health Care Fund's Strategic Moves in Q1 2024: A Focus
Guru Focus· 4 days agoInsight into the Fund's Latest Investment Decisions and Stock Adjustments Vanguard Health Care Fund...